Natera full draft brain (Phases 0/1/1B/2 complete), onboarded 2026-08-13 Design system15 colorsKnowledge base37 notesArtifacts15Sources20 Updated Oct 8Open brand
MI MIIRA Longitudinal multi-timepoint molecular and clinical real-world data from Natera Oncology Biopharma. Design systemNo palette yetKnowledge base0 notesArtifacts0Sources0 No activity yetOpen brand
TO TOMR Treatment on MRD: the category Natera Oncology Biopharma is building around treating at molecular relapse. Design systemNo palette yetKnowledge base0 notesArtifacts0Sources0 No activity yetOpen brand